PDS Biotechnology Corp reports results for the quarter ended in March - Earnings Summary

PDS Biotechnology

15/05/2023 14:32

* PDS Biotechnology Corp  PDSB.OQ  reported a quarterly
adjusted
loss of 32 cents​​ per share for the quarter ended in March. The
mean expectation of seven analysts for the quarter was for a
loss of 31 cents per share.
    * Reported revenue was zero​; analysts expected zero. 
    * PDS Biotechnology Corp's reported EPS for the quarter was
a loss
of 32 cents​.
    * The mean earnings estimate of analysts had risen by
about 5.9%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company. 
    * PDS Biotechnology Corp shares had risen by 4.9% this
quarter and
lost 51.1% so far this year.
    * The company reported a quarterly loss of $9.66 million.
    * Wall Street's median 12-month price target for PDS
Biotechnology
Corp is $18.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 7 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data May
15 at 01:31 p.m. UTC. ​All figures in US dollars unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Mar. 31 2023      -0.31          -0.32          Missed
 Dec. 31 2022      -0.29          -0.67          Missed
 Sep. 30 2022      -0.28          -0.26          Beat
 Jun. 30 2022      -0.28          -0.20          Beat